CODX - Company ID 0001692415
Co-Diagnostics, Inc. trades as CODX. In its fiscal 2025 annual report the company posted revenue of $622.49K, down 84.1% from the prior year and net income of -$46.90M. This page tracks Co-Diagnostics, Inc. through 355 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 8 fiscal years Co-Diagnostics, Inc.'s revenue grew from $7.66K to $622.49K, a compound annual growth rate of 73.3%. Net profit margin expanded from -90827.9% to -7533.6% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Insider trade | 4 | 2026-05-27 |
| Major company event | 8-K | 2026-05-21 |
The largest companies sharing Co-Diagnostics, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
Co-Diagnostics, Inc. reported revenue of $622.49K for fiscal year 2025, a decrease of 84.1% year over year.
In its latest fiscal year Co-Diagnostics, Inc. reported a net loss of $46.90M.